<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Aiello KA</submitter><funding>National Center for Advancing Translational Sciences</funding><funding>NCATS NIH HHS</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>Utah Science, Technology, and Research (USTAR) Initiative</funding><pagination>e0164546</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5087864</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(10)</volume><pubmed_abstract>We use the generalized singular value decomposition (GSVD), formulated as a comparative spectral decomposition, to model patient-matched grades III and II, i.e., lower-grade astrocytoma (LGA) brain tumor and normal DNA copy-number profiles. A genome-wide tumor-exclusive pattern of DNA copy-number alterations (CNAs) is revealed, encompassed in that previously uncovered in glioblastoma (GBM), i.e., grade IV astrocytoma, where GBM-specific CNAs encode for enhanced opportunities for transformation and proliferation via growth and developmental signaling pathways in GBM relative to LGA. The GSVD separates the LGA pattern from other sources of biological and experimental variation, common to both, or exclusive to one of the tumor and normal datasets. We find, first, and computationally validate,</pubmed_abstract><journal>PloS one</journal><pubmed_title>Platform-Independent Genome-Wide Pattern of DNA Copy-Number Alterations Predicting Astrocytoma Survival and Response to Treatment Revealed by the GSVD Formulated as a Comparative Spectral Decomposition.</pubmed_title><pmcid>PMC5087864</pmcid><funding_grant_id>U01 CA-202144</funding_grant_id><funding_grant_id>UL1 TR001067</funding_grant_id><funding_grant_id>UL1 TR-001067</funding_grant_id><funding_grant_id>U01 CA202144</funding_grant_id><pubmed_authors>Aiello KA</pubmed_authors><pubmed_authors>Alter O</pubmed_authors></additional><is_claimable>false</is_claimable><name>Platform-Independent Genome-Wide Pattern of DNA Copy-Number Alterations Predicting Astrocytoma Survival and Response to Treatment Revealed by the GSVD Formulated as a Comparative Spectral Decomposition.</name><description>We use the generalized singular value decomposition (GSVD), formulated as a comparative spectral decomposition, to model patient-matched grades III and II, i.e., lower-grade astrocytoma (LGA) brain tumor and normal DNA copy-number profiles. A genome-wide tumor-exclusive pattern of DNA copy-number alterations (CNAs) is revealed, encompassed in that previously uncovered in glioblastoma (GBM), i.e., grade IV astrocytoma, where GBM-specific CNAs encode for enhanced opportunities for transformation and proliferation via growth and developmental signaling pathways in GBM relative to LGA. The GSVD separates the LGA pattern from other sources of biological and experimental variation, common to both, or exclusive to one of the tumor and normal datasets. We find, first, and computationally validate,</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016</publication><modification>2025-04-22T08:52:00.429Z</modification><creation>2019-03-26T22:48:39Z</creation></dates><accession>S-EPMC5087864</accession><cross_references><pubmed>27798635</pubmed><doi>10.1371/journal.pone.0164546</doi></cross_references></HashMap>